全文获取类型
收费全文 | 8423篇 |
免费 | 489篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 183篇 |
妇产科学 | 108篇 |
基础医学 | 1153篇 |
口腔科学 | 301篇 |
临床医学 | 537篇 |
内科学 | 2058篇 |
皮肤病学 | 226篇 |
神经病学 | 946篇 |
特种医学 | 201篇 |
外科学 | 984篇 |
综合类 | 37篇 |
现状与发展 | 1篇 |
预防医学 | 427篇 |
眼科学 | 319篇 |
药学 | 643篇 |
中国医学 | 17篇 |
肿瘤学 | 740篇 |
出版年
2023年 | 56篇 |
2022年 | 128篇 |
2021年 | 190篇 |
2020年 | 116篇 |
2019年 | 161篇 |
2018年 | 178篇 |
2017年 | 141篇 |
2016年 | 196篇 |
2015年 | 199篇 |
2014年 | 247篇 |
2013年 | 288篇 |
2012年 | 527篇 |
2011年 | 601篇 |
2010年 | 333篇 |
2009年 | 254篇 |
2008年 | 485篇 |
2007年 | 512篇 |
2006年 | 509篇 |
2005年 | 529篇 |
2004年 | 526篇 |
2003年 | 487篇 |
2002年 | 499篇 |
2001年 | 112篇 |
2000年 | 130篇 |
1999年 | 131篇 |
1998年 | 108篇 |
1997年 | 71篇 |
1996年 | 78篇 |
1995年 | 54篇 |
1994年 | 43篇 |
1993年 | 46篇 |
1992年 | 106篇 |
1991年 | 94篇 |
1990年 | 92篇 |
1989年 | 66篇 |
1988年 | 73篇 |
1987年 | 62篇 |
1986年 | 61篇 |
1985年 | 65篇 |
1984年 | 54篇 |
1983年 | 37篇 |
1982年 | 32篇 |
1981年 | 39篇 |
1980年 | 23篇 |
1979年 | 38篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1974年 | 18篇 |
1971年 | 14篇 |
1968年 | 14篇 |
排序方式: 共有8949条查询结果,搜索用时 31 毫秒
101.
Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene 总被引:2,自引:0,他引:2
Osada S Ebihara I Setoguchi Y Takahashi H Tomino Y Koide H 《Kidney international》1999,55(4):1234-1240
BACKGROUND: Recombinant human erythropoietin (rHuEPO) is primarily used for patients with anemia associated with end-stage renal disease. We evaluated the efficacy of EPO gene therapy using adenovirus vector for chronic renal failure mice expressing severe renal anemia. METHODS: Recombinant HuEPO gene transfer to mesothelial cells was performed in vitro and in vivo. Recombinant replication-deficient adenoviruses containing rHuEPO cDNA (AdCMVEPO), E. coli lacZ gene (AdCMVlacZ), or an nonexogenous gene (AdNull as control vector) driven by the cytomegalovirus promotor/enhancer were constructed. The oligosaccharides associated with the rHuEPO from AdCMVEPO-treated mesothelial cells were analyzed. For in vivo study, the DBA/2FG-pcy mouse, a model for human autosomal recessive polycystic kidney disease resulting in chronic renal failure with progressive anemia, was used. RESULTS: The sialylated oligosaccharides associated with the rHuEPO produced in AdCMVEPO-treated mesothelial cells occupied 78 +/- 0.7% of the total oligosaccharide pool. A single intraperitoneal administration of AdCMVEPO induced rHuEPO synthesis in the peritoneal cells and a marked increase in erythrocyte production. The maximal increase in hematocrit (43 +/- 4%) was observed on day 28, and it remained elevated for 40 days. CONCLUSION: These results indicate that intraperitoneal administration of AdCMVEPO improves renal anemia in mice with chronic renal failure and that the mesothelial cell is an appropriate target cell for gene transfer. 相似文献
102.
103.
Yoko Okumura MSc Yoshihisa Nasa PhD Atsushi Sanbe PhD Wakako Toga BSc Satoshi Takeo PhD 《Journal of cardiac failure》1996,2(4):301-310
Background:
Despite the clinical relevance of angiotensin I-converting enzyme (ACE)inhibitors, their effects on impaired vascular function in patients and animals with chronic heart failure (CHF) have not been fully understood. This study was undertaken to determine whether long-term treatment with an ACE inhibitor improved the altered contractile properties of vessels from rats with CHF.Methods and Results:
Twelve weeks after coronary artery ligation, the rats were sacrificed and the isometric tension development of thoracic aorta, pulmonary artery, and mesenteric artery with and without endothelium was examined. Contractile responses to norepinephrine and prostaglandin F2α were augmented in endothelium-intact, but not in endothelium-denuded, thoracic aorta and pulmonary artery segments of the rat with CHF. The contractile response to angiotensin II was augmented in endothelium-denuded mesenteric artery segments of the rat with CHF, which was attenuated by indomethacin or diclofenac sodium but not by bunazosin. Trandolapril (3 mg/kg/d) was administered orally from the 2nd to 12th week after the operation. Treatment with trandolapril reversed the augmented contractile response of the rat with CHF to norepinephrine, prostaglandin F2α, and angiotensin II almost to the levels in the sham-operated rat.Conclusions:
The results demonstrate that an ACE inhibitor is capable of reversing altered vascular function in the rat with CHF, suggesting that vascular beds are possible sites of action for ACE inhibitors in the therapy for CHF. 相似文献104.
Kamei H Koide T Kojima T Hashimoto Y Hasegawa M 《Cancer biotherapy & radiopharmaceuticals》1998,13(3):185-188
Quinones were studied for their growth inhibitory effect on cultured malignant cells. HCT-15 cells derived from human colon carcinoma were used for these experiments. Quinones used were arbutin in the benzoquinone group, juglone and lawsone in the naphthaquinone group, alizarin, emodin, 1,8-dihydroxyanthraquinone, and anthraquinone in the anthraquinone group, and xanthone. Cultured cells were incubated with various concentrations of the quinones for four days in a 5% CO2 incubator, after which cell numbers were counted and significance of differences was analyzed by Student's t test. Anthraquinones and naphthaquinones used in these experiments were more effective than the monocyclic quinone. The 50% suppression dose was less than 12.5 micrograms/ml for them. The number of OH groups seemed to play an important role in the degree of the cell growth inhibition: anthraquinones with 2 or 3 OH groups were more effective than those with no OH group like, 9,10-dioxoanthracene and xanthone. In fact, anthraquinones with no OH group and xanthone were not significantly effective. Flow cytometric histograms revealed a specific pattern; that is, lawsone and juglone in the naphthaquinone group and alizarin and 1,8-dihydroxy-anthraquinone in the anthraquinone group blocked mainly the S phase, and emodin in the anthraquinone group blocked the G1 to S phase of the cell cycle. 相似文献
105.
Seyed Mohammad Mirbod Hideyo Yoshida Chisato Nagata Ryoichi Inaba Yoko Komura Hirotoshi Iwata 《International archives of occupational and environmental health》1992,64(2):93-99
Summary Currently there are no limitations on age of employment on private forestries in Japan. Hence, it was hypothesized that in these kind of enterprises, elderly chain saw operators, or those with long-term exposure, might be at higher risk of developing hand-arm vibration syndrome (HAVS). We consequently investigated the prevalence of HAVS in 447 chain saw workers on private forestries in Gifu Prefecture, Japan, with particular reference to age and exposure period. Of this population, 43 (9.6%) had signs and symptoms of vibration-induced white finger (VWF), and among these workers the severity of finger blanching was significantly correlated (P < 0.01) with the exposure period. Classification of all subjects by exposure period showed that workers with 30 years' exposure had higher prevalences of VWF (20.9%) and numbness of the hands (25.4%) compared to other groups. Significant differences (P < 0.01) were found between the functional capacities of workers with VWF and those of control subjects. We concluded that (a) the elderly chain saw operators and those with longer exposure should be moved to other jobs with a lower or no risk of exposure to vibration, and (b) the results of screening tests, even without cold water immersion (which we did not employ, in order to protect workers' hands), could be helpful for the identification of workers with VWF. 相似文献
106.
Shunsuke Ohtahara M.D. Yasuko Yamatogi M.D. Yoko Ohtsuka M.D. 《Psychiatry and clinical neurosciences》1976,30(3):275-287
The long-term clinical and electroencepha-lographic follow-up studies were carried out for more than three years, up to 14 years in the longest, on 116 cases with Lennox syndrome. And the results of systematic study on changing patterns and outcome have been reported. The follow-up examination was performed also on West syndrome which is closely related with Lennox syndrome; especially the relationship between both syndromes regarding prognosis has been clarified.
- 1 According to the long-term follow-up on 116 cases with Lennox syndrome, there were 98 cases (84.5%) having mental defect. The remaining of seizure was observed in 71 cases (61.2%) and persisted as Lennox syndrome except for one case.
- 2 Generally speaking, the cases with age of onset before two years old showed unfavorable outcome.
- 3 There were 42 cases (36.2%), which were converted from West syndrome and showed markedly unfavorable prognosis in regard to intelligence as well as the remaining of seizure. (31 cases, 77.5%)
- 4 On the other hand, in 23 idiopathic cases, which showed no developmental retardation before onset of seizure, had favorable outcome, and the remaining of seizure was observed in eight cases (34.8%). However, even in such cases, it was noticed that those displaying mental defect at the follow-up attained 14 cases (60.9%). That is to say, it was clarified that persistence of even minor seizures induced mental deterioration.
- 5 The cases with favorable prognosis showed usually a typical slow spike-and-wave pattern electroencephalographically, whereas those with poor prognosis showed mostly an asymmetric or disorganized slow spike-and-wave pattern.
- 6 In many cases displaying signs of brain atrophy with pneumoencephalogram and accompanying overt neurological signs at the initial examination, prognosis is obviously poor.
- 7 From the follow-up examination on 94 cases with West syndrome for three to 15 years, there were 51 cases (54.3%) which was transformed into Lennox syndrome. Among them, those cases with the remaining of seizure at the time of follow-up were 44 (46.8%) out of 94 cases, of which 37 cases (83.8%) had remaining seizure as Lennox syndrome.
- 8 From the above results, it is emphasized that Lennox and West syndromes show close relationship with each other and that a study should be done on the interrelation between their prognosis.
107.
Hasegawa M Kawashima S Shikano M Hasegawa H Tomita M Murakami K Kushimoto H Katsumata H Toba T Yoshikawa H Yoshimura E Koide S Murase M Fujii M 《Nihon Jinzo Gakkai shi》2000,42(2):53-59
Cholesterol arterial embolization is a systemic disease resulting from cholesterol crystal embolization to multiple organs, including the kidney, skin, brain, eye, gastrointestinal tract and extremities. In general, it is associated with high morbidity and mortality, but no optimal treatment has yet been developed. In this paper, we report five patients with cholesterol atheroembolic renal failure. In three of the five patients, combined therapy with corticosteroids and plasma exchange was performed. The three patients survived. On the other hand, the two remaining patients died of multifactorial causes. In this report, the literature on steroid therapy for cholesterol atheroembolic renal disease is reviewed and the efficacy of combined therapy by use of corticosteroids and plasma exchange is evaluated. 相似文献
108.
The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome 总被引:7,自引:0,他引:7
Nakamura T Ushiyama C Suzuki S Hara M Shimada N Ebihara I Koide H 《American journal of nephrology》2000,20(3):175-179
BACKGROUND/AIMS: Detection of podocytes in the urine sediment of children indicates that severe podocyte injury occurred in the glomerulus. Focal glomerulosclerosis (FGS) and minimal-change nephrotic syndrome (MCNS) are kidney diseases characterized by massive proteinuria. The aim of the present study was to determine whether urinary podocytes can be detected in patients with idiopathic FGS or MCNS and whether immunosuppression therapy alters these cells. METHODS: Twenty patients with MCNS (nephrotic stage, n = 12; remission stage, n = 8), 15 patients with FGS and 20 healthy controls were included in the present study. Urinary podocytes were stained by immunofluorescence. All patients with MCNS at the nephrotic stage received prednisolone for 6 months, and all patients with FGS received some form of immunosuppression therapy including prednisolone, cyclophosphamide or mizoribine for 12 months. RESULTS: The 12 nephrotic-stage MCNS patients achieved remission after treatment. Seven of the 15 FGS patients also achieved remission, but the other 8 remained in the nephrotic stage. Urinary podocytes were not detected in any patient with MCNS nor were they detected in healthy controls. Urinary podocytes were detected in all FGS patients (mean, 4.2 cells/ml) before treatment and the number of cells decreased in the 7 patients who achieved remission. The number of podocytes was unchanged in the other 8 patients even after treatment. CONCLUSION: Urinary podocytes may be a useful diagnostic indicator for differentiation between FGS and MCNS. These cells may also mark disease progression in cases of FGS. 相似文献
109.
Nakamura T Ushiyama C Suzuki S Shimada N Sekizuka K Ebihara I Takahashi Y Tanaka A Koide H 《Nephron》2000,86(2):247
110.